Stereotaxis Positioned for 2025 Growth: Buy Rating Backed by Strong Pipeline, Regulatory Approvals, and Solid Financials
Analyst Josh Jennings of TD Cowen reiterated a Buy rating on Stereotaxis (STXS – Research Report), retaining the price target of $5.00.Stay ...
Stereotaxis announces Genesis RMN use by Oulu University Hospital
Stereotaxis (STXS) announced that physicians at Oulu University Hospital in Finland have treated the first patients using the advanced Genesis ...
Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology
ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally ...
Why Stereotaxis (STXS) Is Among the Cheap Robotics Stocks to Invest In Now?
We recently compiled a list of the 10 Cheap Robotics Stocks to Invest In Now. In this article, we are going to take a look at ...
Taiwan News17d
Electrophysiology (EP) Catheters Market is Predicted to Witness Healthy Growth During 2025 – 2033
This comprehensive research combines qualitative and quantitative data from primary and secondary sources. It aims to provide an in-depth understanding of the current market scenario and the impact of ...
Wall Street Journal24d
Stereotaxis Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...